Comparison of the Effectiveness and Safety of the Oral Selective Inhibitor of Nuclear Export, Selinexor, in Diffuse Large B Cell Lymphoma Subtypes

  1. Casasnovas, R.-O.
  2. Follows, G.
  3. Zijlstra, J.M.
  4. Vermaat, J.S.P.
  5. Kalakonda, N.
  6. Choquet, S.
  7. Neste, E.V.D.
  8. Hill, B.
  9. Thieblemont, C.
  10. Cavallo, F.
  11. la Cruz, F.D.
  12. Kuruvilla, J.
  13. Hamad, N.
  14. Jaeger, U.
  15. Caimi, P.F.
  16. Gurion, R.
  17. Warzocha, K.
  18. Bakhshi, S.
  19. Sancho, J.-M.
  20. Schuster, M.
  21. Egyed, M.
  22. Offner, F.
  23. Vassilakopoulos, T.P.
  24. Samal, P.
  25. Ku, M.
  26. Ma, X.
  27. Chamoun, K.
  28. Shah, J.
  29. Canales, M.
  30. Maerevoet, M.
  31. Shacham, S.
  32. Kauffman, M.G.
  33. Goy, A.
  34. Show all authors +
Journal:
Clinical Lymphoma, Myeloma and Leukemia

ISSN: 2152-2669 2152-2650

Year of publication: 2022

Volume: 22

Issue: 1

Pages: 24-33

Type: Article

DOI: 10.1016/J.CLML.2021.07.017 GOOGLE SCHOLAR

Sustainable development goals